The Specialist Pharmacy Service (SPS) has issued a warning about a shortage of Labetalol 50mg, 100mg and 400mg tablets.
The advise, dated April 12, confirmed that the two suppliers of Labetalol in the UK, Mylan and Recipharm, are experiencing supply issues.
“DHSC have been informed there is going to be a supply issue affecting all strengths of labetalol tablets until early-mid May. Supply of labetalol IV is not affected,” read a statement from SPS.
Labetalol, a non-selective beta-blocker with additional alpha-blocking properties, is primarily used for hypertension in pregnancy. It is also licensed for the treatment of mild to severe hypertension, and angina pectoris with existing hypertension.